Stock listing

Inovio Pharmaceuticals, Inc.

Selected listing: INO · BIVA · MXN · MX

Inovio Pharmaceuticals, Inc. (BIVA:INO), Health Technology. Latest release Sep 1, 2026: INOVIO to Participate in Upcoming Investor Conferences.

INO:BIVAMXNMXUpdated October 2, 2026

Ticker: BIVA:INO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BIVA
Currency: MXN

About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. is a public company traded under the ticker INO in the American market. Inovio focuses on developing innovative DNA medicines to treat various diseases, including cancer and infectious diseases.

Latest news from Inovio Pharmaceuticals, Inc.

INOVIO to Participate in Upcoming Investor Conferences

September 1, 2026

INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights

August 12, 2026

INOVIO to Report Second Quarter Financial Results on August 12, 2026

August 4, 2026

INOVIO Announces Pricing of $20.0 Million Public Offering

July 28, 2026

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

May 21, 2026

All Inovio Pharmaceuticals, Inc. news →

Events

Replays

Inovio Pharmaceuticals, Inc. (INO) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 04:30 PM ET
Watch
Inovio Pharmaceuticals, Inc. (INO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 04:30 PM ET
Watch
Inovio Pharmaceuticals, Inc. (INO) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 04:30 PM ET
Watch

Research Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. company profile

View the public company page for Inovio Pharmaceuticals, Inc. on 6ix.

Inovio Pharmaceuticals, Inc. news

Read company news and market updates connected to Inovio Pharmaceuticals, Inc..

Inovio Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Inovio Pharmaceuticals, Inc..